Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy
Authors:
- 7 June 2016
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 49 (2) , 793-802
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 27 references indexed in Scilit:
- The Role of Morphine in Animal Models of Human Cancer: Does Morphine Promote or Inhibit the Tumor Growth?BioMed Research International, 2013
- Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesisBritish Journal of Cancer, 2012
- Morphine and tumor growth and metastasisCancer and Metastasis Reviews, 2011
- The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategiesInternational Journal of Cancer, 2010
- Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responsesBritish Journal of Cancer, 2009
- Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New IndicationsPharmacological Reviews, 2004
- The importance of drug scheduling and recovery phases in determining drug activity: improving etoposide efficacy in BCR-ABL-positive CML cellsEuropean Journal of Cancer, 2002
- Enhancement of Tumor Growth by Morphine and Its Possible Mechanism in Mice.Biological and Pharmaceutical Bulletin, 1993
- Morphine-Induced Delay of Normal Cell Death in the Avian Ciliary GanglionScience, 1985
- Effect of Morphine on Rats bearing Walker Carcinosarcoma 256Nature, 1962